Baidu
map

临床医生成功申报国家自然科学基金的技巧

2012-11-21 MedSci TopScience

选题 1.在临床专业领域申请自然科学基金必须紧扣疾病,尽量建立疾病模型。 2.临床问题和科学假说是申请立项的基础,创新性和前沿性是核心。 3.针对研究基础薄弱的科研人员:新颖是关键,标书高质量的设计是必备要素。 标书一审(评审专家看什么) 1.有没有重要的临床问题或科学问题,是什么问题; 2.科学假说是什么; 3.是否有明显的创新; 4.是否有可行性。 摘要通用模板借鉴 ……

选题

1.在临床专业领域申请自然科学基金必须紧扣疾病,尽量建立疾病模型。

2.临床问题和科学假说是申请立项的基础,创新性和前沿性是核心。

3.针对研究基础薄弱的科研人员:新颖是关键,标书高质量的设计是必备要素。

标书一审(评审专家看什么)

1.有没有重要的临床问题或科学问题,是什么问题;

2.科学假说是什么;

3.是否有明显的创新;

4.是否有可行性。

摘要通用模板借鉴

…… 是……领域的……问题,本项目组前期研究发现…… ,或…问题尚待解决,结合……进展,提出…… 假说,拟用……方法(手段)进行……研究,探索/证明……问题,对阐明……机制/ 揭示……规律有重要意义,为……奠定基础/提供……思路。

立项依据撰写六大重要步骤

1. 选题:大量阅读文献,结合自己的研究基础或从重大健康问题入手。
2. 阐述该问题在国内外的研究现状及今后的发展趋势。总结、肯定他人和自己的前期研究成果的同时,指出目前尚未解决的关键科学问题。
3. 提出假说(详细叙述):引述文献中的证据和自己的研究基础,提出“科学假说”。
4. 针对科学假说,论述研究思路。
5. 如果你承担解决该假说,与别人做该工作的不同之处。
6. 最后点名课题的研究意义及可能的应用前景。

拟解决关键问题的定义

为完成研究目标需重点突破的研究点和技术难点,并简述解决思路。

可行性分析(着重从以下方面进行阐述)

1.充分的立论依据(本课题建立在对前期研究成果和国内外大量文献的分析和推理的基础上,从而确保了立论依据充分和扎实)。

2.坚实的研究基础

3.合理的实验设计

4.可靠的预实验结果

5.成熟的技术条件【实验条件:对于自身单位实验条件偏弱的申请者,可以找附属或邻近单位,开具一份官方信函(包括说明其单位的优势实验条件和必要时给予强有力的技术支持及合作)。】

6.结构合理的创新团队

申请队伍

1.团队人员需围绕课题设计,不要故意添加有一定知名度而实际评审专家知道其不会干活的专家或领导。

2.临床医生申请者一定要加入技术人员及研究生(3-4人)。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2013-03-27 ywding2

    好,有点作用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-12-22 qinbozf

    有指导作用。谢谢。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-12-16 doctorwang105

    值得学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-12-15 heedan

    虽不是临床医生,但也可借鉴

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-11-30 liudongxu

    值得学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-11-30 liudongxu

    值得学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-11-28 hjt7210

    有借鉴意义,谢谢!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1688501, encodeId=143b1688501c8, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Dec 20 15:56:00 CST 2012, time=2012-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5541, encodeId=1f5855416f, content=好,有点作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81a812610, createdName=ywding2, createdTime=Wed Mar 27 14:05:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032873, encodeId=3f8b20328e390, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Mon Dec 10 18:56:00 CST 2012, time=2012-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5241, encodeId=967a524198, content=有指导作用。谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce2d74644, createdName=qinbozf, createdTime=Sat Dec 22 13:45:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5216, encodeId=dc7c5216ff, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18ab46063, createdName=doctorwang105, createdTime=Sun Dec 16 20:36:00 CST 2012, time=2012-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5205, encodeId=f8d75205cd, content=虽不是临床医生,但也可借鉴, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ddfb8595, createdName=heedan, createdTime=Sat Dec 15 23:05:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5135, encodeId=000d5135a5, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:57:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5134, encodeId=c0385134ab, content=值得学习 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f5b65353, createdName=liudongxu, createdTime=Fri Nov 30 10:56:00 CST 2012, time=2012-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5121, encodeId=c88451212e, content=有借鉴意义,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=babf70704, createdName=hjt7210, createdTime=Wed Nov 28 22:55:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5095, encodeId=c78d509540, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccad72562, createdName=chenwenwen1955, createdTime=Mon Nov 26 07:19:00 CST 2012, time=2012-11-26, status=1, ipAttribution=)]
    2012-11-26 chenwenwen1955

    好!

    0

相关资讯

美医生用细菌治疗脑肿瘤而被禁止做研究

有若干项动物实验和少量人类病例报告作为依据,临床医生是否就能绕开研究评审委员会了呢?美国加州的2名神经外科医生这样做了,他们故意用产气肠杆菌感染了3例恶性胶质瘤患者的手术伤口,结果2例患者死于感染。 加州大学戴维斯分校的J. Paul Muizelaar博士和Rudolph J. Schrot博士声称,他们这样做是试图激发患者的免疫应答,并强调这并不是一项研究而是“一种已有的治疗方式”,因此

Baidu
map
Baidu
map
Baidu
map